ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,249,789 | +364.1% | 844,452 | +404.8% | 0.00% | +200.0% |
| Q2 2023 | $269,319 | +82.2% | 167,279 | +228.2% | 0.00% | – |
| Q1 2023 | $147,796 | -66.8% | 50,964 | -62.4% | 0.00% | -100.0% |
| Q4 2022 | $445,080 | -76.9% | 135,695 | -73.4% | 0.00% | -80.0% |
| Q3 2022 | $1,928,000 | +521.9% | 510,169 | +1427.4% | 0.01% | +400.0% |
| Q1 2022 | $310,000 | -24.9% | 33,402 | +25.8% | 0.00% | 0.0% |
| Q2 2021 | $413,000 | -37.7% | 26,559 | -42.5% | 0.00% | 0.0% |
| Q1 2021 | $663,000 | +58.6% | 46,181 | +116.9% | 0.00% | 0.0% |
| Q4 2020 | $418,000 | +162.9% | 21,289 | +88.9% | 0.00% | – |
| Q3 2019 | $159,000 | -61.1% | 11,268 | +9.5% | 0.00% | – |
| Q1 2019 | $409,000 | -43.9% | 10,288 | -51.0% | 0.00% | -100.0% |
| Q4 2018 | $729,000 | -18.5% | 20,997 | -2.8% | 0.00% | 0.0% |
| Q3 2018 | $894,000 | +27.0% | 21,609 | +12.7% | 0.00% | 0.0% |
| Q2 2018 | $704,000 | +146.2% | 19,170 | +161.1% | 0.00% | – |
| Q1 2018 | $286,000 | – | 7,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |